MANAGEMENT

Joe Tartaglia 

CEO

Liam O Neill

CTO

John O Donoghue

Chairman

Advisory Board

PETER MILNER

MD

​Cardiologist. CEO of Heart Metabolics. CEO, AshHill Pharmaceutical Investments. Founder, Optivia Biotechnology. SAB, Novartis Biomedical Research.
​

MICHAEL MARTIN 

MD

​Assoc Professor, UCSF Dept of Epidemiology and Biostatistics. Variety of medial
executive positions.
​
​

PAUL AUERBACH

​MD

Prof of Surgery and Chief of Div of Emergency Medicine, Stanford University. CMO of Healthline Networks. Former VC, Delphi Ventures, COO of  Sterling Healthcare Group.

TED McCLUSKEY

MD/PhD

​Interventional Cardiologist, PhD Pharmacology. 20 years in Biotechnology industry. Former President Sand Hill Angels
​

JEFFREY KAPLAN

MD

Medical Director at Good Samaritan Hospital wound care center and a board certified vascular surgeon. Advisor and investor for Medtech companies.​

TED TUSSING

 

​Venture Associate, TriVentures. Former Dir for Corporate New Ventures at Stanford Univ Medical Center. Director at BioCardia.

​

M. CHRISTINE LEE

MD

​Board-certified dermatologist and Asst Clinical Professor at UCSF. Specialist in Mohs micrographic surgery, skin cancer surgery and reconstruction.